Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise... Show more
Warby Parker is a New York-based, vertically integrated eyewear brand that designs, manufactures, and sells prescription glasses, sunglasses, and contact lenses through a direct-to-consumer model spanning e-commerce and a growing physical retail network. Founded in 2010 and publicly listed in 2021, the company has positioned itself as a more affordable alternative to traditional optical retailers by controlling its own design and supply chain.
Its offering has expanded well beyond eyewear to include eye exams, in-network insurance partnerships, and add-on services such as the Warby Parker Care protection program. As of September 30, 2026, the company operated 364 retail locations. Investors follow the stock closely because Warby Parker combines a recognizable consumer brand with an omni-channel growth strategy, margin expansion, and an emerging push into smart eyewear.
Over the trailing 30 days, WRBY advanced from a closing level of $25.30 in early October 2026 to roughly $31 in early November, a gain of about 22.9%. The move was heavily back-loaded, with the stock trading near $21 in the first week of November before surging after the company's earnings release.
The three-month trend tells a similar but more volatile story. From a starting level near $26 in mid-August, the shares slipped through September and into late October, bottoming near $22 before rebounding. The subsequent earnings-driven rally lifted the stock to around $31, leaving the trailing three-month return in the high-teens percentage range. In short, the stock was range-bound for much of the quarter before a sharp, catalyst-driven breakout.
The primary driver was Warby Parker's third-quarter 2026 report, released on November 5. Net revenue rose 10.4% year over year to $244.7 million, and adjusted EBITDA climbed to $28.6 million, or 11.7% of revenue. Adjusted gross margin expanded 40 basis points to 54.6%, helped by reduced tariffs, shipping efficiencies, optical lab productivity, and higher uptake of progressive lenses. Eye exams grew 30% and the insurance business grew 22% year over year, while e-commerce revenue accelerated to its strongest growth since the company sunset its Home Try-On program.
The clearest sentiment catalyst, however, was Intelligent Eyewear. Management confirmed that pre-orders for its first smart-glasses collection, developed in partnership with Google and Samsung, would begin on November 12, with initial customer deliveries planned for mid-December. Executives described the category as a potential "step function change" in the business and a major growth driver beginning in 2027.
Sentiment was also supported by product momentum, including a collaboration with Rare Beauty by Selena Gomez and several new collections introduced during the quarter. On the other hand, the report carried some caveats: earnings per share of $0.04 came in below the $0.09 consensus estimate, revenue was slightly under expectations, and store traffic remained softer than desired. Analyst reactions were mixed, with Hold ratings from Roth MKM and UBS alongside a maintained Buy from Citizens JMP.
Over the broader three-month window, WRBY's performance reflected a tug-of-war between steady operational execution and a challenging optical-industry backdrop. Management has consistently flagged softer unit growth across eyewear categories and greater pressure on cash-paying customers, which contributed to the stock's mid-quarter pullback toward the low $20s.
At the same time, the company continued expanding its footprint, opening 12 net new stores in the third quarter and remaining on track for roughly 50 openings in 2026, while growing higher-margin services such as eye exams and insurance. The defining event of the quarter was the buildup to the Intelligent Eyewear launch, which shifted the investment narrative from near-term traffic softness toward a longer-term growth opportunity tied to smart glasses.
Tickeron's Trending AI Robots page showcases a curated selection of automated trading strategies from a broader universe of hundreds of AI-driven bots that monitor thousands of tickers. Only top-performing and most relevant robots are featured in this section, giving traders a way to observe automated approaches across different strategies, timeframes, and performance metrics. Each bot operates with its own methodology and risk profile, so the page serves as a discovery tool rather than a one-size-fits-all signal. Investors interested in how algorithmic systems approach names like Warby Parker can explore the page to see which AI robots are currently trending.
The near-term focus is the Intelligent Eyewear launch on November 12 and the pace of pre-orders into the holiday season, since management has framed the category as the company's most significant growth opportunity for 2027. Investors will also watch the company's updated full-year outlook when it next reports, given that guidance now includes only a modest Intelligent Eyewear contribution.
Beyond the product launch, key variables include the health of consumer traffic and unit demand across the optical category, the rollout of eye exams and insurance adoption, gross-margin trends, and the pace of store openings. Macroeconomic conditions affecting discretionary spending and any shifts in tariffs or supply-chain costs also remain relevant. These factors, rather than any single data point, are likely to shape how analysts and the market assess Warby Parker's valuation in the months ahead.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
On November 06, 2026, the Stochastic Oscillator for WRBY moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 56 instances where the indicator left the oversold zone. In 50 of the 56 cases the stock moved higher in the following days. This puts the odds of a move higher at over 89%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where WRBY's RSI Indicator exited the oversold zone, 23 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
WRBY moved above its 50-day moving average on November 05, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +0.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where WRBY advanced for three days, in 227 of 276 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
WRBY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on WRBY as a result. In 57 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
The Moving Average Convergence Divergence Histogram (MACD) for WRBY turned negative on October 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 39 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.
The 10-day moving average for WRBY crossed bearishly below the 50-day moving average on November 03, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.
The 50-day moving average for WRBY moved below the 200-day moving average on October 30, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where WRBY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for WRBY entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. WRBY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.035) is normal, around the industry mean (4.964). WRBY's P/E Ratio (424.667) is considerably higher than the industry average of (40.591). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (3.231) is also within normal values, averaging (56.876).
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WRBY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry PharmaceuticalsOther